A study of V205C at mumps expiry potency in healthy children 12 to 18 months of age
Phase of Trial: Phase III
Latest Information Update: 03 Nov 2009
At a glance
- Drugs MMR-varicella zoster virus vaccine; Varicella vaccines
- Indications Chickenpox; Measles; Mumps; Rubella
- Focus Pharmacodynamics
- Sponsors Merck Sharp & Dohme
- 03 Nov 2009 Investigational drug (Varicella Virus Vaccine Live), actual patient number (1997) added as reported by ClinicalTrials.gov.
- 03 Nov 2009 Actual end date (1 Jul 2001) added as reported by ClinicalTrials.gov.
- 03 Nov 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.